This study by Peng et al compared #Excipient use patterns in marketed and #Patent #Formulations of #MonoclonalAntibodies. Patents helped identify formulation trends. bit.ly/3XlEzws #MAb #HighConcentration #LowConcentration #IV #SC #Vitreous #IM #Lyophilisation #FreezeDrying #Surfactants
November 27, 2025 at 5:48 PM
This study by Peng et al compared #Excipient use patterns in marketed and #Patent #Formulations of #MonoclonalAntibodies. Patents helped identify formulation trends. bit.ly/3XlEzws #MAb #HighConcentration #LowConcentration #IV #SC #Vitreous #IM #Lyophilisation #FreezeDrying #Surfactants
i can't even find them available on the actual maker's website?! maybe they only do limited runs/seasonal batches? 157moments.com/collections/...
DOCUMENTS | 157Moments
DOCUMENTS DOCUMENTS is a fragrance label established in 2021 in Shanghai. Specializing in highconcentration perfumes (20%-30% oil concentration), DOCUMENTS is dedicated to creating novel and profound ...
157moments.com
August 17, 2026 at 8:21 PM
i can't even find them available on the actual maker's website?! maybe they only do limited runs/seasonal batches? 157moments.com/collections/...
The Editorial of our Formulation Special Collection is now online. Many thanks to the guest editors Dr. Qingyan Hu of @regeneron.com and Dr. Frank Li of @elilillyandcompany.bsky.social.
doi.org/10.1093/abt/...
#Formulation #Antibody #mAb #ADC #Lyo #HighConcentration #Coformulation
doi.org/10.1093/abt/...
#Formulation #Antibody #mAb #ADC #Lyo #HighConcentration #Coformulation
Opportunities in formulation development of antibody-based therapeutics
Abstract. Drug product formulation transforms active pharmaceutical ingredients into drug products, ensuring stability, manufacturability, efficacy, and pa
doi.org
September 15, 2025 at 12:23 AM
The Editorial of our Formulation Special Collection is now online. Many thanks to the guest editors Dr. Qingyan Hu of @regeneron.com and Dr. Frank Li of @elilillyandcompany.bsky.social.
doi.org/10.1093/abt/...
#Formulation #Antibody #mAb #ADC #Lyo #HighConcentration #Coformulation
doi.org/10.1093/abt/...
#Formulation #Antibody #mAb #ADC #Lyo #HighConcentration #Coformulation